Diffuse Large B Cell Lymphoma Clinical Trials in Nancy
2 recruitingNancy, France
Showing 1–2 of 2 trials
Recruiting
Phase 2
DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Refractory Diffuse Large B-Cell LymphomaRelapsed Diffuse Large B Cell Lymphoma
ImmunoVaccine Technologies, Inc. (IMV Inc.)102 enrolled50 locationsNCT04920617
Recruiting
Phase 3
Impact of an APA Program on EFS in Patients With Diffuse Large-cell B Lymphoma Treated in 1st Line
Diffuse Large B Cell Lymphoma
Weprom186 enrolled5 locationsNCT04670029